Author:
Ring Barbara,Wrighton Steven A.,Mohutsky Michael
Reference83 articles.
1. Crescent B, Martin MPH, Hales CM, Gu Q, Ogden CL (2019) Prescription drug use in the United States, 2015–2016. https://www.cdc.gov/nchs/data/databriefs/db334-h.pdf. Accessed 9 June 2020
2. Bourgeois FT, Shannon MW, Valim C, Mandl KD (2010) Adverse drug events in the outpatient setting: an 11-year national analysis. Pharmacoepidemiol Drug Saf 19(9):901–910. https://doi.org/10.1002/pds.1984
3. Saravanakumar A, Sadighi A, Ryu R, Akhlaghi F (2019) Physicochemical properties, biotransformation, and transport pathways of established and newly approved medications: a systematic review of the top 200 most prescribed drugs vs. the FDA-approved drugs between 2005 and 2016. Clin Pharmacokinet 58(10):1281–1294. https://doi.org/10.1007/s40262-019-00750-8
4. Cerny MA (2016) Prevalence of non-cytochrome P450-mediated metabolism in Food and Drug Administration-approved oral and intravenous drugs: 2006-2015. Drug Metab Dispos 44(8):1246–1252. https://doi.org/10.1124/dmd.116.070763
5. Segel I (1975) Enzyme kinetics: behavior and analysis of rapid equilibrium and steady-state enzyme systems. Wiley, New York
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献